logo
New coronavirus only ‘one small step from spilling over into humans' and sparking widespread outbreak, say scientists

New coronavirus only ‘one small step from spilling over into humans' and sparking widespread outbreak, say scientists

Scottish Sun09-06-2025
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
A NEW coronavirus may only be "a small step away from spilling over into humans", scientists have warned - sparking fears of another pandemic.
Scientists believe the variant, called HKU5-CoV-2, may infect a broader range of animals than Covid-19 and may have more potential for jumping between species.
1
Dr Michael Letko, a molecular virologist at WSU's College of Veterinary Medicine, lead the research into the concerning variant
Credit: Ted S. Warren/College of Veterinary Medicine/WSU
American scientists fear the virus - found in China - may be one small mutation away from also being able to infect humans, which could lead to a widespread outbreak.
The new study, published in Nature Communications, looked at a lesser-known group of coronaviruses called merbecoviruses.
It includes HKU5 and MERS-CoV, which is responsible for the deadly Middle East Respiratory Syndrome.
First noted in 2012, the virus typically spreads from infected camels to humans causes severe respiratory disease, which can be fatal to 34 per cent of its victims.
The research team, which included scientists at Washington State University (WSU), the California Institute of Technology and the University of North Carolina, sought to understand how merbecoviruses infiltrate the cells of their hosts.
While most bugs in the group seemed to pose little threat to people, scientists said one subgroup, HKU5, has concerning traits.
Michael Letko, a virologist at WSU's College of Veterinary Medicine, said: "Merbecoviruses – and HKU5 viruses in particular – really hadn't been looked at much, but our study shows how these viruses infect cells.
"What we also found is HKU5 viruses may be only a small step away from being able to spill over into humans."
Like other coronaviruses, merbecoviruses rely on a spike protein to bind to receptors and invade host cells.
Dr Letko's team used virus-like particles containing the part of the spike protein responsible for binding to receptors and tested their ability to infect cells in their lab.
World is not prepared for looming Disease X pandemic says Doctor Tedros Ghebreyesus
While most merbecoviruses appeared unlikely to be able to infect humans, HKU5 viruses — which have been found across Asia, Europe, Africa and the Middle East — were shown to use a host receptor known as ACE2, the same used by the SARS-CoV-2 virus that causes Covid-19.
But for now HKU5 viruses can only use the ACE2 gene in bats and can't deploy it on humans nearly as well.
Examining HKU5 viruses found in Asia - where their host is the Japanese house bat - the researchers demonstrated some mutations in the spike protein that may allow the viruses to bind to ACE2 receptors in other species, including humans.
'These viruses are so closely related to MERS, so we have to be concerned if they ever infect humans,' Dr Letko said.
'While there's no evidence they've crossed into people yet, the potential is there — and that makes them worth watching.'
Dr Letko said the study and its methods could be used for future research projects and to help the development of new vaccines and treatments.
What is the new Covid variant confirmed in the UK?
The new strain - called NB.1.8.1 - has been spotted in the parts of the UK, such as Ireland and Wales.
It's also cropped up in Europe, the US and Australia, as well as Egypt, the Maldives, Thailand, China and Hong Kong.
The World Health Organisation (WHO) recently issued a warning over NB.1.8.1, designating it as a "variant under monitoring" due to its global spread and key mutations.
'Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation,' the WHO said.
But while it may not be particularly severe, it may infect people more easily than previous variants, with some evidence suggesting that the variant binds more tightly to human cells.
A recent study that has not yet been peer reviewed suggests that a person infected with NB.1.8.1 may be more likely to pass the virus on to someone else, compared to earlier variants.
The WHO stressed that, based on available evidence, the variant's risk to public health was "low at the global level".
"Currently approved Covid-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease," it added.
Symptoms include sore throat, fatigue, fever, mild cough, muscle aches and a blocked nose.
Some people may also get gastrointestinal symptoms.
It's not the first time concerns have been raised over HKU5.
Earlier this year, Chinese scientists warned that HKU5-CoV-2 may be able to jump straight from bats to humans without another animal in between.
This suggests a higher potential for zoonotic spillover - when a disease spreads from animal to human.
If there is no 'intermediate 'middle animal', it becomes harder to predict and prevent spillover events through interactions such as wildlife trading or hunting.
"There is the potential for this new virus to spillover to human, like previous coronaviruses including SARS-CoV-2," said Dr Gary R McLean, a research fellow at the Imperial College London, who was not involved in the study.
But he noted that, so far, there is no "evidence" that HKU5-CoV-2 can infect people – the paper is based on tests in a laboratory, showing the bug's "potential".
"Hopefully the Chinese authorities now have good surveillance systems in place and the laboratories work to rigid safety standards that minimise the risk of spillover occurring," he said.
The WHO has previously listed MERS and Covid as two of several diseases - alongside the mysterious disease X - that could spark a pandemic, but for which there is no specific treatment or vaccine.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tennis legend goes public with heartbreaking health diagnosis
Tennis legend goes public with heartbreaking health diagnosis

Daily Mirror

time7 hours ago

  • Daily Mirror

Tennis legend goes public with heartbreaking health diagnosis

Monica Seles was diagnosed with myasthenia gravis - a neuromuscular autoimmune disease - in 2022 and the nine-time Grand Slam winner has now chosen to go public Tennis legend Monica Seles has revealed that she was diagnosed with a life-changing neuromuscular disease three years ago. Seles, 51, decided to go public with her rare condition - myasthenia gravis - ahead of this month's US Open. ‌ A nine-time Grand Slam champion, the Serbian-American player won the Australian Open four times, the French Open three times and the US Open twice in her prestigious career. Seles retired in 2008, although her last match was five years prior. ‌ The former world No.1 now deals with a rare condition which causes muscle weakness and can affect most parts of the body. Seles says that she first noticed symptoms around five years ago. ‌ "I would be playing [tennis] with some kids or family members, and I would miss a ball," she told the Associated Press. "I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore. "It took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot." The 51-year-old said that she'd never heard of the condition until seeing a doctor and being referred to a neurologist. Her symptoms included double vision and weakness in her arms. "Just blowing my hair out... became very difficult," she added. "When I got diagnosed, I was like, 'What?!' So this is where - I can't emphasise enough - I wish I had somebody like me speak up about it." Seles - who has two children and is married to Tom Golisano, 83 - is getting used to the 'new normal', categorising her illness with another incident in her life. In April 1993, she was attacked by a man with a knife at a tournament in Hamburg, Germany. The 1995 US Open marked her return to competition, making it to the final before losing to Steffi Grafi. "The way they welcomed me... after my stabbing, I will never forget," Seles recalled. "Those are the moments that stay with you. ‌ She went on to say: "I had to, in tennis terms, I guess, reset - hard reset - a few times. I call my first hard reset when I came to the US as a young 13-year-old (from Yugoslavia). Didn't speak the language; left my family. It's a very tough time. "Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes (everything), and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing - I had to do a huge reset. "And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust'. And that's what I'm doing now."

First day at school for Lanarkshire youngster who was Scotland's youngest Covid patient
First day at school for Lanarkshire youngster who was Scotland's youngest Covid patient

Daily Record

time8 hours ago

  • Daily Record

First day at school for Lanarkshire youngster who was Scotland's youngest Covid patient

Peyton Maguire was just three weeks old when she was diagnosed with Covid in the early days of the pandemic - but has bounced back and is now heading for Primary One A Lanarkshire youngster who was thought to be Scotland's youngest Covid patient when she was just three weeks old is all set to start school. ‌ Five-year-old Peyton Maguire is among the thousands of new starts who will be heading to classrooms across North and South Lanarkshire for the first time on Thursday when she starts in Primary One at Aitkenhead Primary in her home town of Uddingston. ‌ She weighed less than four pounds when she was born two months prematurely by section at University Hospital Wishaw in the first week of the Covid lockdown in March 2020, and the tiny newborn then had to spend time in isolation until finally testing negative and being able to go home for the first time the following month. ‌ Mum Tracy, now 32, and dad AJ, 34 were shocked when NHS Lanarkshire staff first diagnosed their three-week-old baby with the virus in April 2020 – and her story made headlines around the world in the earliest days of the pandemic, with Tracy now saying: 'The head teacher has joked that they're about to have a celebrity join the school.' ‌ Peyton had been delivered early after Tracy was diagnosed with pre-eclampsia, and was being cared for in an incubator in Wishaw's neonatal unit when her parents were told the alarming news that she'd tested positive for Covid-19. Her mum recalled: 'We were told we'd have to stay away from Peyton for 14 days and isolate at home but I pleaded not to be apart from my baby for that long. The staff kindly agreed I could to isolate with her in the hospital while AJ stayed at home. 'Watching the staff at work was incredible. They put their lives at risk to make sure my baby was getting fed and cuddled. Even wearing their PPE, they were determined to hold her. ‌ 'I found the same compassion when I had my second daughter, Harley, who's nearly two now. She was also premature and needed extra care. Peyton was able to visit me and Harley in the maternity unit and the staff were very happy to see her again.' Boxing coaches Tracy and AJ are grateful that Peyton's expert care during the traumatic period ensured she has had no long-term health problems, with Tracy adding: 'She's great except for a touch of asthma – it's a real tribute to the staff who looked after her. I was so moved when I found out some of them had to live away from their own children during the pandemic but were caring for my baby.' ‌ Peyton bounced back after her weeks of treatment at Wishaw General. The five-year-old loves fashion, gymnastics and drawing and can't wait to begin classes at Aitkenhead Primary, where she is all set with a schoolbag in her favourite colour of pink. Tracy said: 'We've been in so many papers, magazines and TV shows, but the most worthwhile thing her story has led us to do was taking part in a conference for neonatal nurses, where I shared my experience. ‌ 'I was also amazed when a woman tapped me on the shoulder in the street and told me she'd read my story and it was the only reason she'd felt confident to go to hospital to have her baby during the pandemic.' 'It's great to hear how she's doing and hard to believe that tiny, vulnerable baby is now a lively five-year-old who's about to go to school.'

Tennis legend Monica Seles, 51, diagnosed with rare muscle-weakening condition as she bravely opens up
Tennis legend Monica Seles, 51, diagnosed with rare muscle-weakening condition as she bravely opens up

Scottish Sun

time10 hours ago

  • Scottish Sun

Tennis legend Monica Seles, 51, diagnosed with rare muscle-weakening condition as she bravely opens up

Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) TENNIS great Monica Seles revealed she has been diagnosed with a rare muscle-weakening condition. Seles, 51, started experiencing double vision and extremely depleted strength in her arms and legs in 2019. Sign up for Scottish Sun newsletter Sign up 2 Monica Seles was diagnosed with a rare neuromuscular autoimmune disease Credit: Getty 2 The tennis star won nine Grand Slams and was the dominant player before her tragic stabbing Credit: AP A long string of tests and scans - delayed by the Covid pandemic - ruled out brain tumours and motor neurone disease. The nine-time Grand Slam champion was eventually diagnosed with myasthenia gravis (MG) in 2022. Now Seles has gone public on neuromuscular autoimmune disease - which currently has no cure - and will raise awareness for the condition with an event around this month's US Open. MG affects most of the body but particularly the muscles that control the eyes - although symptoms can vary from day to day. Approximately 15-20 people per 100,000 - or 0.015 per cent of the population - are affected by MG, which sees the immune system attack the neuromuscular junction where nerves and muscles communicate. Seles told AP: "I would be playing [tennis] with some kids or family members, and I would miss a ball. "I was like, 'Yeah, I see two balls.' "These are obviously symptoms that you can't ignore. "It took me quite some time to really absorb it, speak openly about it, because it's a difficult one. "It affects my day-to-day life quite a lot." BBC presenter taken to hospital after 'real wake up call' working at Wimbledon and putting off medical care Seles won seven of her nine Grand Slams by the age of 18. That included reaching eight Major finals in a row - winning seven - before she was tragically stabbed in April 1993 on court during a match in Hamburg by a fixated fan of Steffi Graf. The Yugoslavia-born star - who switched nationality to USA - returned in 1995 after a two-year absence. She reached the US Open final in her first Major since the stabbing then won the 1996 Australian Open, her ninth and final Grand Slam title. The lefty, who played with a double-handed forehand and backhand, officialy retired in 2008 five years after her final competitive match. Now living in Florida, she told The Athletic about her MG diagnosis: 'I thought, 'OK, just push through it.' "But a couple of instances happened when — on court and in daily life — I realised there was something going on. What is myasthenia gravis? MYASTHENIA GRAVIS is a rare long-term condition that causes muscle weakness. It typically has phases when it improves and phases when it gets worse. MG usually affects most of the body, spreading from the eyes and face to other areas over weeks, months or years. But for some people with myasthenia gravis, only the eyes are affected. It is common for people to have "flare-ups", where symptoms are very troublesome, followed by periods of remission, where symptoms improve. It's an autoimmune condition, which means it's the result of the immune system (the body's natural defence against infection) mistakenly attacking a healthy part of the body. In myasthenia gravis, the immune system damages the communication system between the nerves and muscles, making the muscles weak and easily tired. It can affect people of any age, typically starting in women under 40 and men over 60. Common symptoms of myasthenia gravis include: droopy eyelids double vision difficulty making facial expressions problems chewing and difficulty swallowing slurred speech weak arms, legs or neck shortness of breath and occasionally serious breathing difficulties The symptoms tend to get worse when you're tired. Many people find they're worse towards the end of the day, and better the next morning after getting some sleep. Source: NHS "After coming out of my former country to the IMG Academy, I had to totally reset. "When I became No1, it was a huge reset because everybody treats you differently. "Then obviously when I got stabbed, that was a huge reset. And then when I was diagnosed, it was a huge reset. "The day-to-day part of managing it, depending on my symptoms, is really adjusting, you know. I think anybody else who has Myasthenia Gravis knows it's a continuous adjustment. "After my stabbing, I had to deal with that internally for quite a few years to process it and my MG diagnosis was kind of very similar. "I had to understand my new normal of day-to-day life, what I can do work-wise and different things."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store